Jan 28, 2022, 17:23 by

Jan 28, 2022, 17:23 by

Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced Disease Cytokine Assays to help researchers obtain higher quality scientific research data.

Jan 28, 2022, 17:23 by

Jan 27, 2022, 01:00 by User Not Found

Clinical Research News | The role pharmacists play in the community is the same one they should be playing in clinical research, according to Gerald Finken, founder and CEO of RxE2 whose mission it is to help make that happen. His belief is that “community-based clinical trials” in general can be better for patient care, the pharmacy as a profession, and study sponsors who have long had trouble recruiting enough patients into their studies.

Jan 26, 2022, 01:00 by User Not Found

Clinical Research News | The EU Clinical Trials Register will be implemented on 31 January 2022, with the launch of the harmonized Clinical Trials Information System (CTIS) in all EU and EEA Member States. It is one of the most fundamental changes in the regulatory landscape for clinical trials in Europe. It is both historic and exciting.

Jan 25, 2022, 01:00 by User Not Found

Clinical Research News | After a decade of methodical preparation, Canada’s Ontario Brain Institute's (OBI) neuroinformatics platform, Brain-CODE, launched its open data sharing feature for global brain disorder research.

Jan 24, 2022, 09:26 by User Not Found

Clinical Research News | The pandemic has served to highlight shortcomings of traditional practices around the cold-chain transport of biospecimens for clinical trials—including no backup plans when airports, borders, and study sites unexpectedly close. Even in normal times, default choices such as contracting mostly if not exclusively with premium couriers, can “artificially increase the cost of clinical trial conduct,” in the view of Thomas McDonald, associate director of biospecimen logistics for Bristol Myers Squibb Co. (BMS).

Jan 20, 2022, 01:00 by User Not Found

Clinical Research News | Acceptance of artificial intelligence (AI) in clinical research is on the rise thanks, in part, to its pairing with human expert oversight. The result is faster, more efficient clinical trials with less of the bias associated with purely manual evaluations while sidestepping the potential risks of AI.

Jan 18, 2022, 01:00 by User Not Found

Clinical Research News | Next year, a pan-European pilot study gets underway comparing the performance of hybrid and fully decentralized clinical trial models with conventional brick-and-mortar settings where the endpoints are operational metrics such as recruitment speed and diversity of enrolled populations. The focus of the study—the cornerstone of the broader Trials@Home project—is to see what decentralized approaches are possible across a continent with a mix of different languages, regulatory authorities, and privacy laws.

Jan 14, 2022, 01:00 by User Not Found

Clinical Research News | Technology will continue to play a large role in how we conduct trials, but new ways of working will have to be implemented to truly drive change. During the COVID-19 vaccine trials, several new approaches emerged that helped speed the trials and bring the vaccines to market in record time. One such approach is fast-tracking, or parallelization.

Jan 13, 2022, 13:37 by User Not Found

Clinical Research News | Finalists have been named for the sixth annual Participant Engagement Award. Their work will be highlighted, and a winner will be named at the upcoming 2022 Summit for Clinical Ops Executives (SCOPE), February 7-10 in Orlando, Fla.

Jan 12, 2022, 11:36 by

Indica Labs has announced that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.

Jan 12, 2022, 10:14 by

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Jan 12, 2022, 10:14 by

Pharmaron Beijing Co., Limited, has announced today that it has acquired Aesica Pharmaceuticals Limited ("The Cramlington Site") from Recipharm group. This move will help Recipharm streamline operations in line with its strategic goals and better align with customers' needs.

Jan 12, 2022, 10:14 by

Recipharm has today announced the sale of the solid dose manufacturing site at Fontaine-lès-Dijon, France, to Astrea Pharma. The move is a positive step in streamlining Recipharm's operations and consolidating its position as a top five global Contract Development and Manufacturing Organisation.

Jan 11, 2022, 17:22 by User Not Found

Clinical Research News | Seqster announced today a multi-year partnership with The National Pancreas Foundation, a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, to create the country’s largest, most inclusive pancreatic disease patient registry. The registry uses Seqster technology to connect to any EHR, genomic DNA test, and wearable/remote monitoring device, providing patients with a complete longitudinal health record in real-time.

Jan 11, 2022, 01:00 by User Not Found

Clinical Research News | The scalable, not-for-profit technology platform Kits4Life is helping the clinical trial community divert unused and excess study supplies to healthcare organizations around the world that are qualified to accept humanitarian aid. In doing so, the cross-sector initiative has turned the “meaningless act” of destroying the surplus into an impactful gesture of corporate social responsibility and sustainability.

Jan 10, 2022, 01:00 by User Not Found

Clinical Research News | We spoke with clinical research leaders to gain insights into expectations for the coming year. They predicted direct-to-patient drug shipments, supply chain digitization, payviders, and AI with wearables and other clinical data, and more.

Jan 6, 2022, 17:05 by

Rho Acquires European CRO Dokumeds, Expanding Global Reach and Capabilities Dokumeds brings complementary specialties and multinational footprint in Europe and beyond Research Triangle Park, NC – December 8, 2021 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced that it has acquired Dokumeds, a privately-held European CRO. Established in 1995 and headquartered in Riga, Latvia, Dokumeds has 10 offices and is active across multiple continents. Terms were not disclosed.

Jan 6, 2022, 17:05 by

Veranex, the only global, tech-enabled product development services provider focused on the medical technology industry, today announced its latest acquisition, Worrell, further expanding its offerings and geographic reach. As one integrated company, Veranex delivers compelling strategic, operational, and financial benefits by combining the skills and expertise needed for developing breakthrough medical technologies from concept to commercialization.